International Stem Cell Corp. (OTC:ISCO) has been moving up for two days already. Yesterday, the stock gained another 
4.79%, while its traded volume increased. Though, the reason for the climb remained in mystery.
The records show that ISCO has not released any news on its business lately, thus no one has a clue about its current operations.
The last announcement by the company came up on Jan 18, when they reported that from Nov 11, 2011 through Jan 16 this year ISCO has issued an additional one million shares of common stock to Aspire Capital Fund, LLC for a total consideration of $416,010. The shares were offered and sold in private placement transactions.
On the date when the news was reported, ISCO started to climb up, though the up move lasted a few days only. Presently, the stock is moving up again but its next move is hard to be predicted.
International Stem Cell Corporation is a biotechnology company focused on therapeutic biomedical research and cosmetic products. The company’s 10-Q report came out in mid-November, 2011 and it is not much promising, apart from the 141% increase in the revenue for the three months ended September, 2011. Nevertheless, the higher revenues came at the cost of higher expenses and the company has still not made any profit from its operations.[BANNER]
ISCO derives revenues from its Lifeline Skin Care subsidiary which manufactures cosmetic skin care product developed on the basis of the company’s human stem cell technologies. However, these revenues have been limited so far, thus ISCO needs to raise capital from outside to cover its operations.
Besides, the company’s stockholders are threatened by dilution due to the company’s outstanding convertible preferred stock and warrants.
